The efficacy and safety of rifaximin for the irritable bowel syndrome: A systematic review and meta-analysis
Objectives: Irritable bowel syndrome (IBS) affects 10-15% of the population, and treatment options are limited. Rifaximin is a minimally absorbed antibiotic that has shown efficacy in IBS patients. The objective of our study was to perform a meta-analysis and systematic review of available randomize...
Saved in:
| Main Authors: | , , , |
|---|---|
| Other Authors: | |
| Format: | Review |
| Published: |
2018
|
| Subjects: | |
| Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/15078 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Institution: | Mahidol University |